SBIR/STTR Recipient

Tularik Inc.

Brief Description

Tularik, Inc. engages in the discovery and development of orally available medicines that act through the regulation of gene expression. The company’s drugs include T67, T607, T131, T71, and T487. The T67 is an anti-cancer drug. The T607 would be used for treating gastric cancer and esophageal cancer. The T131 would be used for treating diabetes. The T71 would be used for treating obesity.

Tularik Inc. was acquired by Amgen Inc. for approximately $1.3 billion in 2004.

Timeline 1991. Company founded 1999. Initial public offering...

Thuris Corporation

Brief Description

Thuris Corporation was a biopharmaceutical company focused on medical device solutions to aid in drug development and diagnosis of central nervous system (CNS) disorders including mild cognitive impairment and Alzheimer's disease. Thuris was also developing pharmaceuticals for select CNS orphan and niche indications ranging from ischemia-related conditions, brain inflammation and Huntington's disease. Thuris received 510k FDA clearance for a non-invasive medical device, the NeuroGraph, for diagnosis of neurological and psychiatric disorders over a broad range of brain-...

Synvivia, Inc.

Brief Description

Synvivia is a synthetic biology company that optimizes cell behavior for gene therapy manufacturing, providing a practical solution for genetically encoded biocontainment. The company is building genetically encoded biocontainment technologies that will enable the widespread use of synthetic biology outside of the laboratory.

The company's technology was developed at UC Berkeley with grants from the NSF and DARPA. The work was published in ACS Synthetic Biology and featured as an Editor’s Choice in Science Magazine. Synvivia has exclusive license to the...

Sunesis Pharmaceuticals Inc.

Brief Description

Sunesis is a biopharmaceutical company focused on the development and future commercialization of new oncology therapeutics for the treatment of hematologic and solid tumor cancers. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. The company is focused on advancing its novel kinase-inhibitor pipeline, with an emphasis on establishing proof of concept that it's oral non-covalent BTK inhibitor, vecabrutinib (SNS-062), is effective in the treatment of ibrutinib-resistant chronic lymphocytic...

Algen Biotechnologies

Brief Description

Algen Biotechnologies is building a next-generation, functional genomics-based platform for the discovery of novel therapeutics for cancers with high unmet need. Algen’s research group focuses on developing and applying novel functional genomics technologies to address scientific challenges in drug discovery. The company's biologists and data scientists are collaborating to deliver innovative, patient-centric medicines for the toughest-to-treat diseases.

The company was founded to commercialize technology developed at UC Berkeley while Algen Biotechnologies CEO...

Ambi Robotics

Brief Description

Ambi Robotics offers advanced robot grasping software for logistics and warehouse order fulfillment, allowing robots to grasp a wide variety of objects.

Ambi Robotics grew from the Dexterity Network (Dex-Net) project at UC Berkeley and is led by Dr. Jeff Mahler and Professor Ken Goldberg, experts in robot grasping with a combined 50+ years of experience.

Formerly known as Ambidextrous.

Timeline 2018. Company founded Inventors

Ken Goldberg, Jeffrey Mahler, Matthew Matl

Ansa Biotechnologies

Brief Description

With synthetic DNA fueling innovation in biological research, therapeutics, diagnostics, and biomanufacturing, there is an urgent need for faster and more accurate DNA synthesis. Currently, DNA is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a faster, more accurate, and cleaner enzyme-based DNA synthesis technology. The technique promises to dramatically accelerate innovation in biological research and engineering.

The approach is based on polymerase-...

Serinus Labs

Brief Description Serinus Labs is the world`s first manufacturer of integrated silicon gas sensors. Enabled by cutting-edge nanotechnology, Serinus Labs specializes in providing custom solutions for existing and emerging gas sensor markets such as in industrial health and safety, automotive, consumer electronics and healthcare. Timeline 2017. Company founded. Inventors Ali Javey

Setex Technologies

Brief Description Setex Technologies is the leading manufacturer of gecko-inspired, dry adhesive solutions, offering innovative products that surpass traditional adhesives, gripping materials, and fasteners. Our Setex™ products empower product designers and engineers in both B2B and B2C sectors to create unique, first-to-market designs and address complex manufacturing challenges, enhancing both top-line and bottom-line performance. Founded in 2009 by Dr. Metin Sitti, a Carnegie Mellon University professor, nanoGriptech (now Setex Technologies) has built its expertise through nearly a...

Organos, Inc.

Brief Description Developer of cardiac micro physiological systems designed to offer three-dimensional (3D) human cardiac tissue models for advanced analysis. The company's data science ecosystem is used to illuminate the effects of compounds on human cardiac tissue, ranging from acute cardiotoxicity and safety pharmacology to chronic studies to predict drug-induced arrhythmia, thereby enabling the health industry to perform safer and cheaper drug development activities. Timeline 2016. Company founded. 2020. Company participated in Berkeley...